We are live on ! Find out more
ZBIO

Zenas BioPharma

44 hedge funds and large institutions have $419M invested in Zenas BioPharma in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

62.25% more ownership

Funds ownership: 0%62.25% (+62%)

Holders
44
Holders Change
+44
Holders Change %
% of All Funds
0.63%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
44
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

ZBIO Hedge Fund Activity: Q3 2024 in Review

44 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Zenas BioPharma (ZBIO) for Q3 2024, worth a combined $419M.

Buyers outnumbered sellers: 44 funds opened new ZBIO positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SR One Capital Management, opening a new position worth an estimated $88.3M.

  • 44 institutional investors held Zenas BioPharma (ZBIO) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $419M of Zenas BioPharma stock for Q3 2024.
  • 44 funds opened new Zenas BioPharma positions in Q3 2024 and 0 closed out, a net change of +44 holders.
  • The largest Zenas BioPharma buyer in Q3 2024 was SR One Capital Management, an estimated $88.3M added.

Based on aggregated 13F filings for Q3 2024.